Clinical Trial Update: Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed [NA]

View source ↗

Summary

Completed clinical trial comparing Reinnerva/Lubristil+G versus Vismed for keratoconjunctivitis sicca, evaluating tolerability and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconjunctivitis Sicca

Drugs mentioned

• Reinnerva/Lubristil+G
• Vismed

Snippet

Sponsor: Medivis SRL | Conditions: Keratoconjunctivitis Sicca | NA | Status: COMPLETED